ARCHIVES

Andrew von Eschenbach Sworn In As NCI Director.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Donaldson, Wilson Lead ASTRO; Thomas To Hear Arguments In Cigarette Case; Doll, Peto Honored

November 8, 1991

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

Clinical Trials Approved By NCI CTEP Last Month

February 25, 2011

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

May 8, 1998